Low neurotoxicity of ONX-0914 supports the idea of specific immunoproteasome inhibition as a side-effect-limiting, therapeutic strategy / Laura von Brzezinski [et al.]
  Bibliogr.: p. 243-245. - Abstr. eng.
  In: European Journal of Microbiology and Immunology. - ISSN 2062-509X . - 2017. 7. évf. 3. sz., p. 234-245. : ill.